PLETAL (Otsuka America Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the PLETAL drug offered from Otsuka America Pharmaceutical, Inc.. This Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Otsuka America Pharmaceutical, Inc. |
| NON-PROPRIETARY NAME: | cilostazol |
| SUBSTANCE NAME: | CILOSTAZOL |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Phosphodiesterase 3 Inhibitor [EPC],Phosphodiesterase 3 Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1999-01-15 |
| END MARKETING DATE: | 2017-11-30 |
PLETAL HUMAN PRESCRIPTION DRUG Details:
| Item Description | PLETAL from Otsuka America Pharmaceutical, Inc. |
| LABELER NAME: | Otsuka America Pharmaceutical, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 1999-01-15 |
| END MARKETING DATE: | 2017-11-30 |
| PRODUCT ID: | 59148-003_bb0e7b3b-966b-4d6a-a0d6-6eceeb0fb6a2 |
| PRODUCT NDC: | 59148-003 |
| APPLICATION NUMBER: | NDA020863 |
Other CILOSTAZOL Pharmaceutical Manufacturers / Labelers:
